Collplant ceo yehiel tal to discuss emerging uses of rhcollagen in aesthetic and regenerative medicine at nano.il.2021 conference

Rehovot, israel, sept. 27, 2021 /prnewswire/ -- collplant (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that mr.

CLGN Ratings Summary

CLGN Quant Ranking